Business Department, Université du Québec à Trois-Rivières, Québec, Canada.
Psychol Assess. 2013 Mar;25(1):288-93. doi: 10.1037/a0029262. Epub 2012 Jul 9.
Psychopathy is a clinical construct defined by a cluster of personality traits and behaviors, including grandiosity, egocentricity, deceptiveness, shallow emotions, lack of empathy or remorse, irresponsibility, impulsivity, and a tendency to ignore or violate social norms. The majority of empirical research on psychopathy involves forensic populations most commonly assessed with the Psychopathy Checklist-Revised (PCL-R), a 20-item rating scale that measures 4 related factors or dimensions (Interpersonal, Affective, Lifestyle, and Antisocial) that underpin the superordinate construct of psychopathy. Recently, researchers have turned their attention to the nature and implications of psychopathic features in the workplace. This research has been hampered by the lack of an assessment tool geared to the corporate/organizational world. Here we describe the B-Scan 360, an instrument that uses ratings of others to measure psychopathic features in workplace settings. In this study, large samples of participants used an online survey system to rate their supervisors on the B-Scan 360. Exploratory and confirmatory factor analyses supported a reliable 20-item, 4-factor model that is consistent with the PCL-R 4-factor model of psychopathy. Although more research is needed before the B-Scan 360 can be used in organizational settings, we believe that these results represent an important step forward in the study of corporate psychopathy.
精神病态是一种临床概念,由一系列人格特征和行为定义,包括自大、自我中心、欺骗、浅薄的情感、缺乏同理心或悔恨、不负责任、冲动和忽视或违反社会规范的倾向。大多数关于精神病态的实证研究涉及法医人群,最常用于评估的是《精神病态检查表修订版》(PCL-R),这是一个 20 项的评分量表,用于衡量 4 个相关因素或维度(人际关系、情感、生活方式和反社会),这些因素构成了精神病态的高级概念。最近,研究人员将注意力转向了工作场所中精神病态特征的性质和影响。这项研究受到缺乏针对企业/组织环境的评估工具的阻碍。在这里,我们描述了 B-Scan 360,这是一种使用他人的评分来衡量工作场所中精神病态特征的工具。在这项研究中,大量参与者使用在线调查系统对他们的主管进行了 B-Scan 360 评分。探索性和验证性因素分析支持了一个可靠的 20 项、4 因素模型,该模型与精神病态的 PCL-R 4 因素模型一致。虽然在 B-Scan 360 可以用于组织环境之前还需要更多的研究,但我们相信这些结果代表了在企业精神病态研究方面向前迈出的重要一步。